Completed PHASE1 INTERVENTIONAL 2-arm NCT04330547

Use of Analgesic Treatment to Reduce Signs of Pain in Patients With Disorders of Consciousness.

Use of Analgesic Treatment to Reduce Signs of Pain in Patients With Disorders of Consciousness: a Double-blind Placebo-controlled Clinical Study.

Sponsor: University of Liege

Conditions Disorders of Consciousness Minimally Conscious State Post-comatose Non-communicative Patients Severe Brain Injury Vegetative State

Interventions Analgesic administration Placebo administration

Updated 5 times since 2020 Last updated: Apr 28, 2021 Started: Feb 21, 2018 Primary completion: Feb 19, 2019 Completion: Apr 28, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04330547, this PHASE1 trial focuses on Disorders of Consciousness and Minimally Conscious State and remains completed. Sponsored by University of Liege, it has been updated 5 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jun 2021 — Jul 2024 [monthly]

Completed PHASE1

Status: Active Not Recruiting → Completed · Phase: PHASE2 → PHASE1
Jan 2021 — Jun 2021 [monthly]

Active Not Recruiting PHASE2
May 2020 — Jan 2021 [monthly]

Active Not Recruiting PHASE2

First recorded

Feb 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Liege

Data source: University of Liege

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Liège, Belgium